7. Lowe, S. W. (1995). Cancer therapy and p53.
8. Huber, A . O . and Evan, G. I. (1998). Traps to catch unwary oncogenes.
9. Cook-Deegan, R. (1994).
W. W. Norton, New York.
10. Krakauer, D. C. and Payne, R. J. H. (1997). The evolution of virus-induced apoptosis.
11.. Le Grand, E. K. (1997). An adaptationist view of apoptosis.
B I B L I O G R A P H Y A N D N O T E S 333
C H R O M O S O M E 1 8
Geoff Lyon and Peter G o r n e r ' s blow-by-blow account of the development of gene therapy,
1. Verma, I. M. and Somia, N. (1997). G e n e t h e r a p y - promises, problems and prospects.
2. Carter, M. H. (1996). Pioneer Hi-Bred: testing for gene transfers. Harvard Business School Case Study N 9 - 5 9 7 - 0 5 5 .
3. Capecchi, M. R. (1989). Altering the g e n o m e by homologous recombination.
4. First, N. and T h o m s o n , J. (1998). F r o m cows stem therapies?
C H R O M O S O M E 1 9
T h e promises and perils of genetic screening have been discussed at great length in many books, articles and reports, but few stand out as essential sources of wisdom. Chandler Burr's
1. Lyon, J. and G o r n e r , P. (1996).
2. E t o , M., Watanabe, K. and Makino, I. (1989). Increased frequencies of apolipoprotein E2 and E4 alleles in patients with ischemic heart disease.
3. Lucotte, G., Loirat, F. and Hazout, S. (1997). Patterns of gradient of apolipoprotein E allele *4 frequencies in western E u r o p e .
4. K a m b o h , M. I. (1995). Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
3 3 4 G E N O M E
5. Cook-Degan, R. (1995).
Norton, New York.
6. Kamboh, M. I. (1995). Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
(1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.
7. Bickeboller, H.
8. Caldicott, F.
Nuffield Council on Bioethics, London.
9. Bickeboller, H.
10. Maddox, J. (1998).
11. Cookson, C. (1998). Markers on the road to avoiding illness.
12. Wilkie, T. (1996). The people who want to look inside your genes.